Case 2

Clinical and Experimental Dermatology

Volumn 28, Issue 1, 2003, Pages 105-106

  Nayak, N ^a,c   Friedmann, P S ^a,b   Healy, E ^a,b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

Author keywords

Bleomycin; Flagellatedermatosis

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; ETOPOSIDE; METHOTREXATE; PREDNISOLONE; VINCRISTINE; ANTINEOPLASTIC ANTIBIOTIC;

AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; ERYTHEMA; FLAGELLATE DERMATOSIS; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PRURITUS; SKIN DISEASE; SKIN MANIFESTATION; TREATMENT OUTCOME; BACK; CHEMICALLY INDUCED DISORDER; DRUG ERUPTION; HYPERPIGMENTATION; PATHOLOGY;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; BACK; BLEOMYCIN; DRUG ERUPTIONS; ERYTHEMA; HUMANS; HYPERPIGMENTATION; LYMPHOMA, NON-HODGKIN; MALE;

EID: 0037272579     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2003.01114.x     Document Type: Article

References (6)

1. Umezawa H. Bleomycin and other antitumour antibiotics of high molecular weight. Antmicrob Agent Chemother 1965: 5: 1079-85.
2. Evans WE, Yee GC, Crom WR et al. Clinical pharmacology of bleomycin and cisplatin. Head Neck Surg 1991; 4: 98-110.
3. Rubiez NG, Salem Z, Dibbs R et al. Bleomycin-induced urticarial flagellate drug hypersensitivity reaction. Int J Dermatol 1999; 38: 131-41.
4. Wright AL, Bleehan SS, Champion AE. Reticulate pigmentation due to bleomycin. Light- and electron-microscopic studies. Dermatologica 1990; 180: 255-7.
5. Guillet G, Guillet MH. Cutaneous pigmented stripes and bleomycin treatment. Arch Dermatol 1986; 122: 381-2.
6. Duhra P, Ilchyshyn A, Das RN. Bleomycin-induced flagellate erythema. Clin Exp Dermatol 1991; 16: 216-7.